UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.744

Sortiert nach

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy

Annals of oncology, 2015-01, Vol.26 (1), p.75-80

2015

Link zum Volltext

Verfügbarkeit prüfen

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment

Endocrine-related cancer, 2011-10, Vol.18 (5), p.565-577

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

British journal of cancer, 2014-06, Vol.110 (12), p.2847-2854

2014

Link zum Volltext

Verfügbarkeit prüfen

Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience

Endocrine-related cancer, 2005-07, Vol.12 (Supplement_1), p.S113-S117

2005

Link zum Volltext

Verfügbarkeit prüfen

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy

Breast cancer research and treatment, 1998-03, Vol.48 (2), p.107-116

1998

Link zum Volltext

Verfügbarkeit prüfen

Preoperative chemotherapy induces apoptosis in early breast cancer

The Lancet (British edition), 1997-03, Vol.349 (9055), p.849-849

1997

Link zum Volltext

Verfügbarkeit prüfen

Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2469-2476

2005

Link zum Volltext

Verfügbarkeit prüfen

397 Extreme loss of immunoreactive phosphoproteins during routine fixation of primary breast cancer

European journal of cancer supplements, 2010, Vol.8 (3), p.173-173

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-10-02: The impact of intrinsic subtypes and molecular features on aromatase inhibitor induced reduction of proliferation marker of Ki67 in primary ER+ breast cancer: A POETIC study (CRUK/07/015)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-10-02

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-01

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay

Journal of clinical pathology, 1994-10, Vol.47 (10), p.900-905

1994

Link zum Volltext

Verfügbarkeit prüfen

Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer

Clinical cancer research, 2006-02, Vol.12 (3), p.1024s-1030s

2006

Link zum Volltext

Verfügbarkeit prüfen

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group

The American journal of gastroenterology, 2017-02, Vol.112 (2), p.337-345

2017

Link zum Volltext

Verfügbarkeit prüfen

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease

Gut, 2020-03, Vol.69 (3), p.462

2020

Link zum Volltext

Verfügbarkeit prüfen

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer

Clinical cancer research, 2003-01, Vol.9 (1 Pt 2), p.524S-32S

2003

Link zum Volltext

Verfügbarkeit prüfen

Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study

Alimentary Pharmacology & Therapeutics (Suppl), 2018-11, Vol.48 (9), p.924-932

2018

Link zum Volltext

Verfügbarkeit prüfen

Oestrogen formation in breast: clinical and biological importance

Journal of endocrinology, 1996-09, Vol.150 Suppl, p.S59

1996

Link zum Volltext

Verfügbarkeit prüfen

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

Clinical cancer research, 2001-05, Vol.7 (5), p.1230-1236

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer

Journal of clinical pathology, 1998-01, Vol.51 (1), p.34-37

1998

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-01-07: Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-01-07

2013

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Antitumor Activity and Pharmacodynamic Studies with the Farnesyl Protein Transferase Inhibitor R115777 in Human Breast Cancer

Clinical cancer research, 2001-11, Vol.7 (11), p.3544-3550

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD07-07: Prediction of antiproliferative response to lapatinib by HER3 in an exploratory analysis of HER2-non-amplified (HER2−) breast cancer in the MAPLE presurgical study (CRUK E/06/039)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD07-07-PD07-07

2012

Link zum Volltext

Verfügbarkeit prüfen

The control and biological importance of intratumoural aromatase in breast cancer

Journal of steroid biochemistry and molecular biology, 1996, Vol.56 (1), p.145-150

1996

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Phenotype after 20-Year Follow-Up of the Royal Marsden Tamoxifen Breast Cancer Prevention Trial (RMTBCPT)

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.1046-1046

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.744

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.466)
Mit Volltextzugriff
(1.522)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.685)
Japanisch
(217)
Französisch
(45)
Ungarisch
(14)
Deutsch
(2)
Russisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(964)
Humans
(708)
Life Sciences & Biomedicine
(633)
Female
(441)
Male
(435)
Adult
(271)
Biological And Medical Sciences
(266)
Middle Aged
(252)
Technology
(248)
Medical Sciences
(232)
Neurosciences & Neurology
(224)
Neurosciences
(174)
Computer Science
(173)
Computer Science, Artificial Intelligence
(171)
Magnetic Resonance Imaging
(170)
Aged
(163)
Physical Sciences
(137)
Chemistry
(125)
Magnetic Resonance Imaging - Methods
(123)
Cardiovascular System & Cardiology
(122)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy

Preoperative chemotherapy induces apoptosis in early breast cancer

Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

397 Extreme loss of immunoreactive phosphoproteins during routine fixation of primary breast cancer

Abstract P2-10-02: The impact of intrinsic subtypes and molecular features on aromatase inhibitor induced reduction of proliferation marker of Ki67 in primary ER+ breast cancer: A POETIC study (CRUK/07/015)

Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker

Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay

Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease

Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer

Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study

Oestrogen formation in breast: clinical and biological importance

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer

Abstract P4-01-07: Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer

Preclinical Antitumor Activity and Pharmacodynamic Studies with the Farnesyl Protein Transferase Inhibitor R115777 in Human Breast Cancer

Abstract PD07-07: Prediction of antiproliferative response to lapatinib by HER3 in an exploratory analysis of HER2-non-amplified (HER2−) breast cancer in the MAPLE presurgical study (CRUK E/06/039)

The control and biological importance of intratumoural aromatase in breast cancer

Immunohistochemical Phenotype after 20-Year Follow-Up of the Royal Marsden Tamoxifen Breast Cancer Prevention Trial (RMTBCPT)

Suchergebnisse filtern